Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-26-000005

Chief Commercial Officer acquired 26,482 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mottiwala Aziz · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-15 Exercise or conversion : show line 1 in the form +26,482 74,536 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2026-03-15 Exercise or conversion : show line 2 in the form Restricted Stock Units −4,790 0 D
2026-03-15 Exercise or conversion : show line 3 in the form Restricted Stock Units −8,148 8,148 D
2026-03-15 Exercise or conversion : show line 4 in the form Restricted Stock Units −8,020 16,040 D
2026-03-15 Exercise or conversion : show line 5 in the form Restricted Stock Units −5,524 16,574 D
Loading xslF345X05/wk-form4_1773779561.xml…